BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11771108)

  • 1. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S
    Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
    Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D; Khan M; Gul A; Alam R
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C; Trinquand C; Bloch-Michel E
    Eur J Ophthalmol; 1998; 8(4):207-16. PubMed ID: 9891891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S; Munteanu GH
    Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G
    Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF; Khaitova KN; Grishakova MB
    Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lodoxamide as adjuvant therapy in patients with dry eye.
    Petricek I; Pokupec R; Petricek G; Salopek-Rabatić J
    Coll Antropol; 2001; 25 Suppl():149-52. PubMed ID: 11817007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT; Easty DL; Collum LM; Benedict-Smith A; Hillery M; Parsons DG
    Eur J Ophthalmol; 1992; 2(3):144-9. PubMed ID: 1450659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H; Bitiren M; Aslan OS; Ozardali I
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
    Zhang W; Lin Z
    Yan Ke Xue Bao; 2000 Sep; 16(3):214-6. PubMed ID: 12579651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM; Ricca V; Tosca MA; Buscaglia S; Ciprandi G
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.